메뉴 건너뛰기
International MS Journal
Volumn 12, Issue 3, 2005, Pages 73-
Treatment adherence: What is the best that can be achieved?

(1)  Hutchinson, Michael a  

a NONE
Author keywords

[No Author keywords available]
Indexed keywords

INTERFERON BETA SERINE; MITOXANTRONE;
EID: 28244488627     PISSN: 13528963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (7)
References (8)
  • 1
    • 0030912908 scopus 로고    scopus 로고
    • Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis
    • Mohr DC, Goodkin DE, Likosky W, Gatto N, Baumann KA, Rudick RA. Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch Neurol 1997; 54: 531-533.
    • (1997) Arch Neurol , vol.54 , pp. 531-533
    • Mohr, D.C.1    Goodkin, D.E.2    Likosky, W.3    Gatto, N.4    Baumann, K.A.5    Rudick, R.A.6
  • 2
    • 0030332317 scopus 로고    scopus 로고
    • Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: Relationship to adherence to treatment
    • Mohr DC, Goodkin DE, Likosky W, Gatto N, Neilley LK, Griffin C et al. Therapeutic expectations of patients with multiple sclerosis upon initiating interferon beta-1b: relationship to adherence to treatment. Mult Scler 1996; 2: 222-226.
    • (1996) Mult Scler , vol.2 , pp. 222-226
    • Mohr, D.C.1    Goodkin, D.E.2    Likosky, W.3    Gatto, N.4    Neilley, L.K.5    Griffin, C.6
  • 3
    • 0042932742 scopus 로고    scopus 로고
    • Interrupted therapy: Stopping and switching of the beta-interferons prescribed for MS
    • Tremlett HL, Oger J. Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. Neurology 2003; 61: 551-554.
    • (2003) Neurology , vol.61 , pp. 551-554
    • Tremlett, H.L.1    Oger, J.2
  • 4
    • 13844315516 scopus 로고    scopus 로고
    • Stopping beta-interferon therapy in multiple sclerosis: An analysis of stopping patterns
    • O'Rourke KE, Hutchinson M. Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns. Mult Scler 2005; 11: 46-50.
    • (2005) Mult Scler , vol.11 , pp. 46-50
    • O'Rourke, K.E.1    Hutchinson, M.2
  • 5
    • 20144382021 scopus 로고    scopus 로고
    • Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis
    • Rio J, Porcel J, Tellez N, Sanchez-Betancourt A, Tintore M, Arevalo MJ et al. Factors related with treatment adherence to interferon beta and glatiramer acetate therapy in multiple sclerosis. Mult Scler 2005; 11: 306-309.
    • (2005) Mult Scler , vol.11 , pp. 306-309
    • Rio, J.1    Porcel, J.2    Tellez, N.3    Sanchez-Betancourt, A.4    Tintore, M.5    Arevalo, M.J.6
  • 6
    • 20144384545 scopus 로고    scopus 로고
    • The Goldman Consensus statement on depression in multiple sclerosis
    • Goldman Consensus Group. The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler 2005; 11: 328-337.
    • (2005) Mult Scler , vol.11 , pp. 328-337
  • 7
    • 0002972171 scopus 로고    scopus 로고
    • Treatment of depression in multiple sclerosis: Review and meta-analysis
    • Mohr DC, Goodkin DE. Treatment of depression in multiple sclerosis: review and meta-analysis. Clinical Psychology: Science and Practice 1999; 6: 1 -9.
    • (1999) Clinical Psychology: Science and Practice , vol.6 , pp. 1-9
    • Mohr, D.C.1    Goodkin, D.E.2
  • 8
    • 10944258663 scopus 로고    scopus 로고
    • Review of mitoxantrone in the treatment of multiple sclerosis
    • Jeffery DR, Herndon R. Review of mitoxantrone in the treatment of multiple sclerosis. Neurology 2004; 63 (Suppl 6): S19-S24.
    • (2004) Neurology , vol.63 , Issue.SUPPL. 6
    • Jeffery, D.R.1    Herndon, R.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.